U.S. Senators Introduce Bill to Clarify Oversight Responsibilities for Pharmaceutical Compounding

The Senate Health, Education, Labor and Pensions (HELP) Committee introduced new legislation May 15 that would improve the safety of compounded human drugs by making clear the compounding oversight responsibilities of state and federal authorities. The committee plans to meet next Wednesday for an executive session to consider the bill—S. 959, the Pharmaceutical Compounding Quality and Accountability Act—along with other newly introduced legislation that will strengthen and improve the drug distribution supply chain.

AVMA continues to actively engage with congressional offices and stakeholders to ensure that veterinarians and animal patients have access to the medications that they need.

The Senate HELP Committee has released new background materials on the draft legislation ahead of its meeting on May 22, including an updated:

In addition, the committee has shared a video of its May 9 hearing titled, “Pharmaceutical Compounding: Proposed Legislative Solution,” where many HELP committee members address misinformation about the proposal.

For more information, see the committee’s press release announcing the bill.

Comments are closed.